US Stock MarketDetailed Quotes

X4 Pharmaceuticals (XFOR)

Watchlist
  • 3.880
  • +0.150+4.02%
Close Jun 11 16:00 ET
  • 3.919
  • +0.039+0.99%
Pre 08:15 ET
365.96MMarket Cap-1.87P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

X4 Pharmaceuticals (XFOR) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Product revenue, net2.5M91.27%
License and other revenue239K8.73%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United Kingdom28.6M81.48%
United States6.5M18.52%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.48%
Sample Name
Sample Code
 +1.20%
Sample Name
Sample Code
 -2.64%
4
ProShares Ultra Energy
DIG
-2.80%
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
-2.93%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +6.08%
Sample Name
Sample Code
 +3.63%
Sample Name
Sample Code
 +3.45%
4
Amer Sports
AS
+3.22%
5
NetEase
NTES
+2.95%
View More
Middle East conflict spreads to the stock market! How should investors respond?
A critical window for U.S.-Iran talks has opened! According to Bloomberg, the U.S. and Iran are 'close' to signing an agreement around the u Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -